7 July 2021 in Science Translational Medicine
Triggers of innate immune signaling in the CNS of patients with amyotrophic lateral sclerosis and frontotemporal degeneration (ALS/FTD) remain elusive. We report the presence of cytoplasmic double-stranded RNA (cdsRNA), an established trigger of innate immunity, in ALS-FTD brains carrying C9ORF72 intronic hexanucleotide expansions that included genomically encoded expansions of the G4C2 repeat sequences. The presence of cdsRNA in human brains was coincident with cytoplasmic TAR DNA binding protein 43 (TDP-43) inclusions, a pathologic hallmark of ALS/FTD. Introducing cdsRNA into cultured human neural cells induced type I interferon (IFN-I) signaling and death that was rescued by FDA-approved JAK inhibitors. In mice, genomically encoded dsRNAs expressed exclusively in a neuronal class induced IFN-I and death in connected neurons non–cell-autonomously. Our findings establish that genomically encoded cdsRNAs trigger sterile, viral-mimetic IFN-I induction and propagated death within neural circuits and may drive neuroinflammation and neurodegeneration in patients with ALS/FTD.
1 June 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Effective de-implementation models often include replacement of an ineffective practice with an alternative. We co-developed patient education materials as a replacement strategy for inappropriate post-procedural antibiotics in cardiac device procedures. Lessons learned and developed materials may be used to promote infection prevention in other periprocedural settings.
18 March 2025 in Transplant Infectious Disease
30 October 2024 in Infection Control & Hospital Epidemiology
A surveillance system for measuring patient-level antimicrobial adverse drug events (ADE) may support stewardship activities, however, design and implementation questions remain. In this national survey, stewardship experts favored simple, laboratory-based ADE definitions although there were tensions between feasibility, ability to identify attribution without chart review, and importance of specific ADE.
1 September 2026 in Antimicrobial Stewardship & Healthcare Epidemiology
Background: Ralstonia species are environmental Gram-negative bacilli increasingly linked to healthcare-associated bloodstream infection (BSI) outbreaks from contaminated medical solutions. We describe an outbreak of Ralstonia mannitolilytica BSI in which the source was identified and withdrawn within 24 hours. Methods: Following an unusual cluster of R. mannitolilytica blood cultures on 29 September 2024 at a 700-bed tertiary-care hospital in Oman, we conducted a multidisciplinary investigation including chart review, hospitalwide surveillance, environmental and product sampling, antimicrobial susceptibility testing, and pulsed-field gel electrophoresis (PFGE) of clinical and product isolates. Results: Between 29 September and 8 October 2024, 21 patients met the case definition (median age 9 yr; 62% pediatric; 62% male; 95% immunocompromised; 86% with central venous access). Newly introduced pre-filled 10 mL 0.9% sodium chloride vials from a single manufacturer yielded R. mannitolilytica with concordant clinical and product antimicrobial susceptibility profiles. PFGE of 18 clinical isolates and one product isolate demonstrated 100% genetic relatedness, confirming a single-clone outbreak. The implicated product was withdrawn within 24 hours of cluster recognition. Thirteen of 21 patients had their central catheters removed; all received intravenous trimethoprim–sulfamethoxazole. Two patients experienced bacteremia recurrence after initial line retention; no outbreak-related deaths occurred. Conclusions: Prefilled saline vials can serve as the source of clonal R. mannitolilytica BSI outbreaks in immunocompromised patients. Laboratory-driven cluster detection, multidisciplinary coordination, and rapid product suspension enabled source identification within 24 hours and limited outbreak size and severity. Vigilance after introduction of new pharmaceutical products and prompt catheter removal in catheter-associated Ralstonia BSI are essential.
4 November 2024 in Infectious Diseases in Clinical Practice
Background: Neuroborreliosis is involvement of the nervous system in Lyme disease and can often be overlooked as a diagnosis in patients presenting with cranial neuropathies and meningitis in an endemic area. There can be variability in presentation with respect to the involved cranial nerves, making the diagnosis challenging. To the best of our knowledge, there have been no reported cases of Lyme disease cranial neuropathy occurring with simultaneous periorbital skin and soft tissue inflammation in the literature. Case: We present the case of a healthy 25-year-old man who presented to the emergency department with headache, diplopia, and left eye pain after experiencing fever, malaise, and a recent history of unilateral facial palsy that improved a few weeks prior. He lived in a Lyme disease endemic area and often encountered ticks. He was found to have an abduction deficit in his left eye, preseptal and postseptal orbital inflammation with bilateral optic perineuritis, and a lymphocytic pleocytosis in the cerebrospinal fluid accompanied by an elevated antibody index, consistent with a diagnosis of Lyme neuroborreliosis. He was treated with doxycycline and empiric bacterial coverage, with symptom resolution at follow-up. Conclusion: This case represents an unusual combination of cranial neuropathies and is the first report of orbital inflammation driven by Lyme neuroborreliosis, thought to be caused by contiguous spread of inflammation from affected portions of the nervous system. Although neuroborreliosis is less commonly encountered in the United States than in Europe, providers should maintain a high index of suspicion for this entity when patients present with multiple cranial neuropathies in an endemic area and not exclude Lyme disease on the basis of skin and soft tissue inflammation.